Outset Medical Incの最新の1株当たり利益は$-0.8で、$-0.74の予想を打ちつける。
Outset Medical Inc OMの前四半期の収益はどうでしたか?
Outset Medical Incの前四半期の収益は$-0.8です。
Outset Medical Incの収益見積もりはいくらですか?
7人のウォール街のアナリストによると、Outset Medical Incの収益見積もりは$36.64Mから$32.43Mの範囲です。
Outset Medical Incの収益品質スコアはどれくらいですか?
Outset Medical Incの収益品質スコアはB+/50.64775です。このスコアは、収益性、成長、キャッシュ生成と資本配分、レバレッジの4つの次元に基づいています。
Outset Medical Incはいつ収益を報告しますか?
Outset Medical Incの次の収益報告は2026-11-04に予定されています
Outset Medical Incの予想収益はいくらですか?
ウォール街のアナリストによると、Outset Medical Incの予想収益は$30.72Mです。
Outset Medical Incは収益予想を上回りましたか?
Outset Medical Incの最近の収益は$31.64Mで、予想をビート。
主要データ
前終値
$4.5
始値
$4.51
当日レンジ
$4.49 - $4.65
52週レンジ
$3 - $16.16
取引高
27.5K
平均取引高
190.6K
配当利回り
--
1株当たり利益(TTM)
-4.15
時価総額
$83.5M
OMとは何ですか?
Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. The company is headquartered in San Jose, California and currently employs 310 full-time employees. The company went IPO on 2020-09-15. The company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by virtually anyone. Tablo comprises various components, including Tablo Console, Tablo Cartridge, and Tablo Data Ecosystem. The Tablo Console is a proprietary, compact, and mobile machine consisting of an integrated water purification, on-demand dialysate production system and simple-to-use touchscreen interface with 3D animations. The company also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.